Cargando…
Scintigraphic Imaging of Neovascularization With (99m)Tc-3PRGD(2) for Evaluating Early Response to Endostar Involved Therapies on Pancreatic Cancer Xenografts In Vivo
BACKGROUND: Molecular imaging targeting angiogenesis can specifically monitor the early therapeutic effect of antiangiogenesis therapy. We explore the predictive values of an integrin αvβ3-targeted tracer, (99m)Tc-PEG(4)-E[PEG(4)-c(RGDfK)](2) ((99m)Tc-3PRGD(2)), for monitoring the efficacy of Endost...
Autores principales: | Jin, Xiaona, Dong, Chengyan, Zheng, Kun, Shi, Ximin, Liu, Yu, Huo, Li, Wang, Fan, Li, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236135/ https://www.ncbi.nlm.nih.gov/pubmed/35769548 http://dx.doi.org/10.3389/fonc.2021.792431 |
Ejemplares similares
-
(99m)Tc-3PRGD(2) SPECT Predicts the Outcome of Endostar and Cisplatin Therapy in Xenograft Animals
por: Sun, Wei, et al.
Publicado: (2019) -
Anti-tumor Effect of Integrin Targeted (177)Lu-3PRGD(2) and Combined Therapy with Endostar
por: Shi, Jiyun, et al.
Publicado: (2014) -
Direct attenuation correction for (99m)Tc-3PRGD(2) chest SPECT lung cancer images using deep learning
por: Xing, Haiqun, et al.
Publicado: (2023) -
Advances in Clinical Oncology Research on (99m)Tc-3PRGD2 SPECT Imaging
por: Xiao, Liming, et al.
Publicado: (2022) -
Biodistribution and scintigraphic evaluation of 99mTc-Mannan complex
por: Sanguri, Sweta, et al.
Publicado: (2016)